A foot-volume-measuring device using 3D imagery and AI to automatically monitor heart failure patients, reducing hospital stays by 165,000 bed-days/year

使用 3D 图像和 AI 的足部体积测量设备可自动监测心力衰竭患者，每年可减少 165,000 个床位日的住院时间

• 批准号: 10047020
• 金额: $ 44.1万
• 依托单位: HEARTFELT TECHNOLOGIES LTD
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10047020
• 关键词: foot; volume; measuring; device; using

The catalyst behind Heartfelt was a conversation with a heart transplant surgeon in 2015 that prompted a simple question: 'Do you know that half the people I operate on wouldn't require surgery at all if they had reported their symptoms in time?'. Further research enabled the Heartfelt founders to unearth the hidden problem of "non-adherent' patients. These are mostly elderly people, often living alone, many with deteriorating mental capacity, who are unable to follow the advice given to them by their doctors. Instead of calling for help as their symptoms get worse, they end up as emergency hospital admissions. There are over 60 million people globally with heart failure - a terminal illness with worse survival statistics than most cancers. The cost of treating them is substantial, roughly £1.7billion/year in the UK alone, most of which is spent delivering expensive and often preventable hospital treatments. Heartfelt's vision is to address this problem with an autonomous monitoring device that sits in the patient's home, measuring changes in foot volume -- key indicator of heart problems -- and triggering alerts and thus timely medical intervention. It has the potential to improve the life quality of millions of heart patients, and also to save the NHS money and reduce waiting time in A&E by freeing up hospital beds. Heartfelt's monitor is fully automatic and requires no interaction with the patient. The foot volume data is uploaded to the cloud and analysed using artificial intelligence, which watches for critical changes. It is complicated, cutting-edge technology, protected by patent but utterly simple to use. Pilot trials on hundreds of UK-based patients have demonstrated the effectiveness of the monitors. The main aim of the project is to finalise the development of the next-generation device, readying it for manufacturing and regulatory approvals ahead of starting commercialisation.

Heartfelt背后的催化剂是与2015年的心脏移植外科医生进行的对话，这引起了一个简单的问题：“您知道，我经营的一半的人如果及时报告了症状，根本不需要手术？”。进一步的研究使衷心的创始人能够发掘出“非依从者”患者的隐藏问题。这些都是过去的人，通常是独自生活的人，许多人无法遵循医生给他们的建议。他们的症状变得更糟，因为他们的症状变得更糟，而不是急诊率会遭受全球症状的责任。他们仅在英国就有大约17亿英镑/年，其中大多数用于提供昂贵的医院治疗方法，这是通过在患者家中使用的自主监测设备来解决这个问题，测量脚踏量的变化 - 关键的脚步 - 以及触发了预防效果的关键指示，并触发了及时的医疗干预。通过释放医院的病床在A＆E等待时间。 Heartfelt的显示器是完全自动的，不需要与患者的相互作用。脚卷数据被上传到云，并使用人工智能进行分析，该脚步观察了关键的变化。它是复杂的，尖端的技术，受专利的保护，但完全易于使用。对数百名英国患者的试验试验已证明了监视器的有效性。该项目的主要目的是对下一代设备的开发进行调整，准备在开始商业化之前进行制造和监管批准。